GLP-1 users are defined as patients with an approved claim for at least one of the following GLP-1 medications in the prior 12 months: Mounjaro, Ozempic, Rybelsus, Saxenda, Wegovy, and Zepbound
Obesity, in particular, exacerbates PsD severity and treatment resistance, underscoring the need for integrated therapeutic strategies
Will retatrutide be expensive
Draw the calculated amount of bacteriostatic water with a mixing syringe, then inject it slowly down the inside wall of the peptide vial
Documentation becomes especially important during staggered implementation phases
For employer-sponsored self-insured plans, you may also have the option to request an independent external review